Canada· CA-DIN-02391619
JAMP-DICYCLOMINE HCL
A dicycloverine product containing dicyclomine hydrochloride, registered in Canada by JAMP PHARMA CORPORATION. The same ATC class is registered in 3 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Dicycloverine is registered in 3 of 19 countries.
Countries holding a registration under ATC A03AA07 (dicycloverine), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Dicycloverine · ATC A03AA07
3 / 19 countries
- Canada
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dicycloverine costs, country by country.
Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dicycloverine · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- US United States$0.62 (acquisition cost)
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- DICYCLOMINE HYDROCHLORIDE
- Manufacturer
- JAMP PHARMA CORPORATION
- Country
- Canada (CA)
- ATC code
- A03AA07
- ATC class
- Dicycloverine
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
389 interactions on record for dicycloverine.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dicycloverine · interactions on record
389 records
- 6 severe
- 194 moderate
- 17 minor
- 172 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- TopiramatN02CX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dicycloverine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDicycloverine 10mg tabletsAdvanz Pharma
- United StatesDicyclomineNuCare Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Dicycloverine, Dicycloverine Focus Pharmaceuticals
- Latvia · Trigan-Sp
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad9667d9-b2d7-48ca-832a-8521f7c7375f GET /v1/drugs/ad9667d9-b2d7-48ca-832a-8521f7c7375f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02391619",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A03AA07",
"schedule": [
"Ethical"
],
"drug_code": "87694",
"strengths": [
"10 MG"
],
"ahfs_class": null,
"substances": [
"DICYCLOMINE HYDROCHLORIDE"
],
"product_categorization": null
}See everything about dicycloverine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.